These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26038517)

  • 21. HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil.
    Albuquerque LC; Mendonça IR; Cardoso PN; Baldaçara LR; Borges MR; Borges Jda C; Pranchevicius MC
    Rev Soc Bras Med Trop; 2014; 47(1):38-46. PubMed ID: 24603735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hematological and Clinical Features Associated with Initial Poor Treatment Outcomes in Visceral Leishmaniasis Patients with and without HIV Coinfection in Gondar, Northwest Ethiopia.
    Ademe M; Osorio Y; Howe R; Atnafu S; Mulaw T; Fikre H; Travi BL; Hailu A; Melby PC; Abebe T
    Trop Med Infect Dis; 2023 Jan; 8(1):. PubMed ID: 36668943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis.
    d'Ettorre G; Ceccarelli G; Carnevalini M; Forcina G; Zaffiri L; Massetti AP; Mastroianni CM; Vullo V
    Acta Trop; 2006 Aug; 99(1):83-7. PubMed ID: 16962979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.
    Russo R; Laguna F; López-Vélez R; Medrano FJ; Rosenthal E; Cacopardo B; Nigro L
    Ann Trop Med Parasitol; 2003 Oct; 97 Suppl 1():99-105. PubMed ID: 14678637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leishmania / HIV co-infections.
    Desjeux P
    Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case Report: No Response to Liposomal Daunorubicin in a Patient with Drug-Resistant HIV-Associated Visceral Leishmaniasis.
    Gow NJ; Davidson RN; Ticehurst R; Burns A; Thomas MG
    PLoS Negl Trop Dis; 2015; 9(8):e0003983. PubMed ID: 26305562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent visceral leishmaniasis relapses in HIV co-infected patients are characterized by less efficient immune responses and higher parasite load.
    Takele Y; Mulaw T; Adem E; Womersley R; Kaforou M; Franssen SU; Levin M; Taylor GP; Müller I; Cotton JA; Kropf P
    iScience; 2023 Feb; 26(2):105867. PubMed ID: 36685039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
    Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.
    Adriaensen W; Dorlo TPC; Vanham G; Kestens L; Kaye PM; van Griensven J
    Front Immunol; 2017; 8():1943. PubMed ID: 29375567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
    Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
    HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmaniasis in immunosuppressed individuals.
    van Griensven J; Carrillo E; López-Vélez R; Lynen L; Moreno J
    Clin Microbiol Infect; 2014 Apr; 20(4):286-99. PubMed ID: 24450618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient.
    de Vallière S; Mary C; Joneberg JE; Rotman S; Bullani R; Greub G; Gillmore JD; Buffet PA; Tarr PE
    Am J Trop Med Hyg; 2009 Aug; 81(2):209-12. PubMed ID: 19635871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge.
    Patole S; Burza S; Varghese GM
    Int J Infect Dis; 2014 Aug; 25():204-6. PubMed ID: 24927662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical and evolutional characteristics of visceral leishmaniasis in patients with HIV infection].
    Delgado Fernández M; García Ordoñez MA; Martos Pérez F; Reguera Iglesias JM; Jiménez Oñate F; Colmenero Castillo JD
    An Med Interna; 1997 Oct; 14(10):506-10. PubMed ID: 9424140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
    Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
    AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe.
    Rihl M; Stoll M; Ulbricht K; Bange FC; Schmidt RE
    J Infect; 2006 Jul; 53(1):e25-7. PubMed ID: 16274744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia.
    Diro E; Lynen L; Gebregziabiher B; Assefa A; Lakew W; Belew Z; Hailu A; Boelaert M; van Griensven J
    Trop Med Int Health; 2015 Jan; 20(1):8-16. PubMed ID: 25329449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia.
    Mohammed R; Fikre H; Schuster A; Mekonnen T; van Griensven J; Diro E
    Curr Ther Res Clin Exp; 2020; 92():100583. PubMed ID: 32382359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The performance of direct agglutination tests (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV co-infection.
    Hailu A; Berhe N
    Ann Trop Med Parasitol; 2002 Jan; 96(1):25-30. PubMed ID: 11989530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.